SEC Comment Letter 0000000000-24-008483 to Tectonic Therapeutic, Inc. (TECX)
Tectonic Therapeutic, Inc.
Date: July 26, 2024 · CIK: 0001681087 · Accession: 0000000000-24-008483
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280909
Letter
July 26, 2024 Daniel Lochner Chief Financial Officer Tectonic Therapeutic, Inc. 490 Arsenal Way Suite 210 Watertown, MA 02472 Re:Tectonic Therapeutic, Inc. Registration Statement on Form S-1 Filed July 19, 2024 File No. 333-280909 Dear Daniel Lochner: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Courtney T. Thorne, Esq.
Show Raw Text
July 26, 2024
Daniel Lochner
Chief Financial Officer
Tectonic Therapeutic, Inc.
490 Arsenal Way
Suite 210
Watertown, MA 02472
Re:Tectonic Therapeutic, Inc.
Registration Statement on Form S-1
Filed July 19, 2024
File No. 333-280909
Dear Daniel Lochner:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Courtney T. Thorne, Esq.